Nitrofurantoin 5 MG/ML Oral Suspension — RxCUI 311989
RxNorm drug concept · Semantic clinical drug
RxCUI 311989
Semantic clinical drug · SCD
● Current RxNorm concept 11 FDA products
11 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI311989
Official nameNitrofurantoin 5 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnitrofurantoin 25 MG per 5 ML Oral Suspension; nitrofurantoin 25 MG in 5 mL Oral Suspension
FDA products mapped11
Package NDCs mapped11
Reported Medicaid activity (SDUD)18,644 prescriptions · 43 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Nitrofurantoin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Nitrofurantoin is an antibiotic specifically for urinary tract infections — think bladder infections, not kidney infections. It works by concentrating in your urine where it kills...
- What exactly is nitrofurantoin used for?
- Yes, every time. Taking nitrofurantoin with food isn't just about avoiding an upset stomach — food actually helps your body absorb more of the medication, so it works better. Even...
- Do I really need to take it with food every single time?
🕸️ Concept Web — How Nitrofurantoin 5 MG/ML Oral Suspension Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Nitrofurantoin 5 MG/ML Oral Suspension
RxCUI 311989 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Nitrofurantoin
7454IN
-
Nitrofurantoin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Furadantin
258353BN
-
Furadantin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Nitrofurantoin Oral Suspension
373100SCDF -
Nitrofurantoin Oral Liquid Product
1159262SCDG -
Nitrofurantoin Oral Product
1159263SCDG -
Nitrofurantoin Oral Suspension [Furadantin]
365870SBDF -
Furadantin Oral Liquid Product
1173999SBDG -
Furadantin Oral Product
1174000SBDG -
Oral Suspension
316969DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Nitrofurantoin Oral Suspension
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Nitrofurantoin 5 MG/ML
316359SCDC -
Nitrofurantoin 5 MG/ML Oral Suspension [Furadantin]
207790SBD -
Nitrofurantoin 5 MG/ML [Furadantin]
568530SBDC
-
Nitrofurantoin 5 MG/ML
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Nitrofurantoin 5 MG/ML
SCDC · 316359 -
Nitrofurantoin Oral Suspension
SCDF · 373100 -
Nitrofurantoin Oral Liquid Product
SCDG · 1159262 -
Nitrofurantoin Oral Product
SCDG · 1159263
Brand-Name Concepts
-
Nitrofurantoin 5 MG/ML Oral Suspension [Furadantin]
SBD · 207790 -
Nitrofurantoin 5 MG/ML [Furadantin]
SBDC · 568530 -
Nitrofurantoin Oral Suspension [Furadantin]
SBDF · 365870 -
Furadantin Oral Liquid Product
SBDG · 1173999 -
Furadantin Oral Product
SBDG · 1174000 -
Furadantin
BN · 258353
📦 FDA Products & Package NDCs
11 products · 11 package NDCs
11 package NDCs map to RxCUI 311989 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 16571-0888-06 | 1 BOTTLE in 1 CARTON (16571-888-06) / 60 mL in 1 BOTTLE | Nitrofurantoin | Rising Pharma Holdings, Inc. | 2024-02-01 |
| 31722-0491-23 | 1 BOTTLE in 1 CARTON (31722-491-23) / 230 mL in 1 BOTTLE | NITROFURANTOIN | Camber Pharmaceuticals, Inc. | 2025-07-02 |
| 40032-0450-11 | 1 BOTTLE in 1 CARTON (40032-450-11) / 230 mL in 1 BOTTLE | Nitrofurantoin | Novel Laboratories, Inc. | 2014-09-08 |
| 43386-0450-11 | 1 BOTTLE in 1 CARTON (43386-450-11) / 230 mL in 1 BOTTLE | Nitrofurantoin | Lupin Pharmaceuticals,Inc. | 2015-05-21 |
| 64980-0593-24 | 1 BOTTLE in 1 CARTON (64980-593-24) / 230 mL in 1 BOTTLE | Nitrofurantoin | Rising Pharma Holdings, Inc. | 2023-05-11 |
| 65162-0689-88 | 230 mL in 1 BOTTLE, GLASS (65162-689-88) | Nitrofurantoin | Amneal Pharmaceuticals LLC | 2011-03-24 |
| 69238-2512-09 | 1 BOTTLE, GLASS in 1 CARTON (69238-2512-9) / 230 mL in 1 BO... | Nitrofurantoin | Amneal Pharmaceuticals NY LLC | 2021-05-31 |
| 70069-0829-01 | 1 BOTTLE, GLASS in 1 CARTON (70069-829-01) / 230 mL in 1 BO... | Nitrofurantoin | Somerset Therapeutics, LLC | 2025-02-26 |
| 70377-0118-31 | 1 BOTTLE, GLASS in 1 CARTON (70377-118-31) / 230 mL in 1 BO... | NITROFURANTOIN | Biocon Pharma Inc | 2024-11-15 |
| 70954-0496-10 | 230 mL in 1 BOTTLE (70954-496-10) | Nitrofurantoin | ANI Pharmaceuticals, Inc. | 2023-04-17 |
| 72603-0176-01 | 1 BOTTLE in 1 CARTON (72603-176-01) / 230 mL in 1 BOTTLE | Nitrofurantoin | NorthStar Rx LLC | 2023-04-17 |
Observed labelers:
Rising Pharma Holdings, Inc. (2) ·
Amneal Pharmaceuticals LLC (1) ·
Amneal Pharmaceuticals NY LLC (1) ·
ANI Pharmaceuticals, Inc. (1) ·
Biocon Pharma Inc (1) ·
Camber Pharmaceuticals, Inc. (1)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.